FDA Approves GORE VIABAHN VBX Balloon Expandable Endoprosthesis for Expanded Use in Complex Aortic Repair

AI-generated NewsSnap summary based on source reporting.
Published: 2026-10-14
Category: health
Source: PR Newswire (via BioSpace)

W. L. Gore & Associates' medical business has received U.S. Food and Drug Administration (FDA) approval for an expanded indication of its GORE VIABAHN VBX Balloon Expandable Endoprosthesis (VBX Stent Graft). The device is now approved for use in fenestrated and branched endovascular aortic repair (FEVAR and BEVAR), marking the first on-label bridging stent graft for these complex procedures. Three-year clinical outcomes from the EMBRACE Registry supported the safety and effectiveness of the device.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai